子痫前期神经系统并发症的脑生物标志物
这项观察性研究纳入南非子痫前期产科不良事件生物样本库的妇女,发现子痫前期患者血浆神经丝轻链、tau和胶质纤维酸性蛋白浓度高于血压正常孕妇,且伴神经系统并发症者tau和胶质纤维酸性蛋白升高更明显,提示这些脑生物标志物可能是子痫前期脑并发症诊断及预测的候选标志物。
要点
- 子痫前期患者血浆神经丝轻链、tau和胶质纤维酸性蛋白浓度较血压正常孕妇升高。
- 伴神经系统并发症的子痫前期患者tau和胶质纤维酸性蛋白升高更明显。
- 脑生物标志物可能是子痫前期脑并发症诊断及预测的候选标志物。
核心结论
- 血浆神经丝轻链、胶质纤维酸性蛋白和tau是子痫前期脑并发症诊断及可能预测的候选生物标志物。
研究设计与样本
- 观察性研究,纳入南非子痫前期产科不良事件生物样本库的妇女,子痫前期病例诊断时、血压正常对照入院分娩时采集血浆样本。
- 检测血浆神经丝轻链、tau、胶质纤维酸性蛋白、胎盘生长因子、可溶性fms样酪氨酸激酶1和可溶性内皮糖蛋白浓度,并对15名妇女亚组分析脑脊液炎症标志物和白蛋白。
- 分析校正了孕龄、癫痫发作及分娩至采样时间、母亲年龄和产次。
主要发现
- 与28名血压正常孕妇相比,146名子痫前期患者血浆神经丝轻链高2.18倍(95%CI 1.64-2.88)、tau高2.17倍(95%CI 1.49-3.16)、胶质纤维酸性蛋白高2.77倍(95%CI 2.06-3.72)。
- 72名伴神经系统并发症(子痫、皮质盲和卒中)的子痫前期患者与31名无肺水肿、溶血、肝酶升高和低血小板计数或神经系统并发症的子痫前期患者相比,tau高2.99倍(95%CI 1.92-4.65)、胶质纤维酸性蛋白高3.22倍(95%CI 2.06-5.02),血管生成标志物也升高但幅度较小。
- 20名伴溶血、肝酶升高和低血小板计数的子痫前期患者与无肺水肿、溶血、肝酶升高和低血小板计数或神经系统并发症的子痫前期患者相比,神经丝轻链高1.64倍(95%CI 1.06-2.55)、tau高4.44倍(95%CI 1.85-10.66)、胶质纤维酸性蛋白高1.82倍(95%CI 1.32-2.50),血管生成标志物无差异。
- 23名伴肺水肿的子痫前期患者与无肺水肿、溶血、肝酶升高和低血小板计数或神经系统并发症的子痫前期患者相比,所有生物标志物均无差异。
- 伴多种神经系统并发症的子痫前期患者与仅伴子痫者相比,血浆tau和胶质纤维酸性蛋白浓度升高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is no tool to accurately predict who is at risk of developing neurologic complications of preeclampsia, and there is no objective method to determine disease severity. OBJECTIVE: We assessed whether plasma concentrations of the cerebral biomarkers neurofilament light, tau, and glial fibrillary acidic protein could reflect disease severity in several phenotypes of preeclampsia. Furthermore, we compared the cerebral biomarkers with the angiogenic biomarkers soluble fms-like tyrosine kinase 1, placental growth factor, and soluble endoglin. STUDY DESIGN: In this observational study, we included women from the South African Preeclampsia Obstetric Adverse Events biobank. Plasma samples taken at diagnosis (preeclampsia cases) or admission for delivery (normotensive controls) were analyzed for concentrations of neurofilament light, tau, glial fibrillary acidic protein, placental growth factor, soluble fms-like tyrosine kinase 1, and soluble endoglin. The cerebrospinal fluid concentrations of inflammatory markers and albumin were analyzed in a subgroup of 15 women. Analyses were adjusted for gestational age, time from seizures and delivery to sampling, maternal age, and parity. RESULTS: Compared with 28 women with normotensive pregnancies, 146 women with preeclampsia demonstrated 2.18-fold higher plasma concentrations of neurofilament light (95% confidence interval, 1.64-2.88), 2.17-fold higher tau (95% confidence interval, 1.49-3.16), and 2.77-fold higher glial fibrillary acidic protein (95% confidence interval, 2.06-3.72). Overall, 72 women with neurologic complications (eclampsia, cortical blindness, and stroke) demonstrated increased plasma concentrations of tau (2.99-fold higher; 95% confidence interval, 1.92-4.65) and glial fibrillary acidic protein (3.22-fold higher; 95% confidence interval, 2.06-5.02) compared with women with preeclampsia without pulmonary edema; hemolysis, elevated liver enzymes, and low platelet count; or neurologic complications (n=31). Moreover, angiogenic markers were higher, but to a lesser extent. Women with hemolysis, elevated liver enzymes, and low platelet count (n=20) demonstrated increased plasma concentrations of neurofilament light (1.64-fold higher; 95% confidence interval, 1.06-2.55), tau (4.44-fold higher; 95% confidence interval, 1.85-10.66), and glial fibrillary acidic protein (1.82-fold higher; 95% confidence interval, 1.32-2.50) compared with women with preeclampsia without pulmonary edema; hemolysis, elevated liver enzymes, and low platelet count; or neurologic complications. There was no difference shown in the angiogenic biomarkers. There was no difference between 23 women with preeclampsia complicated by pulmonary edema and women with preeclampsia without pulmonary edema; hemolysis, elevated liver enzymes, and low platelet count; or neurologic complications for any of the biomarkers. Plasma concentrations of tau and glial fibrillary acidic protein were increased in women with several neurologic complications compared with women with eclampsia only. CONCLUSION: Plasma neurofilament light, glial fibrillary acidic, and tau were candidate biomarkers for the diagnosis and possibly prediction of cerebral complications of preeclampsia.
引用
- Bergman L, Hastie R, Bokström-Rees E, et al. Cerebral biomarkers in neurologic complications of preeclampsia. Am J Obstet Gynecol. 2022. PMID: 35257666. doi:10.1016/j.ajog.2022.02.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。